Skip to main content

Advertisement

Log in

Lip hypertrophy due to cyclosporine therapy

  • Images in nephrology
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Bhattacharyya I, Islam MN, Yoon TY, Green JG, Ohja J, Liu JJ, Cohen DM. Lip hypertrophy secondary to cyclosporine treatment: a rare adverse effect and treatment considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(4):469–74.

    Article  PubMed  Google Scholar 

  2. Bostrom A, Bharath H, Saulewicz A, Narayanan AS. Cyclosporin A affects signaling events differentially in human gingival fibroblasts. J Dent Res. 2005;84:532–6.

    Article  CAS  PubMed  Google Scholar 

  3. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis. 2009;53(5):760–9.

    Article  CAS  PubMed  Google Scholar 

  4. Gomez E, Sanchez-Nunez M, Sanchez JE, Corte C, Aguado S, Portal C, et al. Treatment of cyclosporine-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant. 1997;12:2694–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All the authors have declared no competing interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhijeet Saha.

About this article

Cite this article

Kapoor, K., Saha, A. & Dubey, N.K. Lip hypertrophy due to cyclosporine therapy. Clin Exp Nephrol 18, 168–169 (2014). https://doi.org/10.1007/s10157-013-0808-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-013-0808-6

Keywords

Navigation